Abstract
As an emerging country, Indonesia is still in the process of imple-menting prophylaxis as a standard of care for managing hemophilia with limited real-world evidence in Indonesian patients. This case series details the effects of tertiary prophylaxis with an intermediate dose of factor VIII concentrate on bleeding outcomes and musculoskeletal function in three Indonesian adolescents suffering from severe haemophilia A and associated arthropathy. [Paediatr Indones. 2025;65:268-72; DOI: https://doi.org/10.14238/pi65.3.2025.268-72 ].
| Original language | English |
|---|---|
| Pages (from-to) | 268-272 |
| Number of pages | 5 |
| Journal | Paediatrica Indonesiana(Paediatrica Indonesiana) |
| Volume | 65 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - May 2025 |
Keywords
- arthropathy
- factor VIII
- hemophilia
- intermediate dose
- prophylactic therapy
Fingerprint
Dive into the research topics of 'Bleeding outcomes and musculoskeletal function in adolescents having severe hemophilia A: a case series'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver